Axovia Therapeutics Unveils New Preclinical Data for AXV-201, for Treatment of Genetic Obesity Caused by MC4R Mutations, at ASGCT Provided by GlobeNewswire May 15, 2025, 11:00:00 AM ...

The first testing centre will be operated by SingHealth and located at the National Heart Centre. Read more at ...

Find out about new obesity drugs currently in phase III clinical trials and how well these medicines might work. ... . cAMP boosts the signals that trigger insulin release and slow stomach emptying.

A landmark new study has found that obese teens who are given semaglutide weight loss drugs like Ozempic and Wegovy, may see an improvement in their mental health, including a reduced risk of suicide.

Motion sickness brain circuit may provide new options for treating obesity . Taylor Barnes. 713-798-4710. Houston, TX - Mar 24, 2025. ... Mouse models offer an abundance of molecular and genetic tools ...

Amid the rising buzz around Ozempic and similar weight-loss drugs, a group of 58 researchers is challenging the way obesity is defined and diagnosed, arguing that current methods fail to capture ...

Now new research at Memorial Sloan Kettering Cancer Center (MSK) suggests obesity may also be linked to some genetic mutations that drive specific subtypes of cancer. “Our results show that obesity ...

Ms. Belluz is a health journalist based in Paris. She is co-writing a book about nutrition and health. “Obesity is a disease,” Oprah Winfrey declared after disclosing her weight loss with an ...

Variant Bio, a small biotech company based in Seattle, is using genetic information from Indigenous people to develop drugs for obesity and diabetes. By Brendan Borrell When Stephane Castel first ...